Kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of gastric cancer patient

A technology for peripheral blood circulation and tumor cells, applied in separation methods, chemical instruments and methods, measurement devices, etc., can solve the problems of inability to obtain tissue samples, and the inability of tissue samples to assess the CEA status of patients, avoiding edge effects and achieving good stability. , the effect of reducing the loss of cells

Inactive Publication Date: 2020-09-08
山东凯歌智能机器有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to overcome the inability of patients with advanced or recurrent gastric cancer to obtain tissue samples by real-time or repeated puncture, and thus to evaluate the CEA status of patients, the present invention provides a non-diagnostic detection method for CEA gene mutations in peripheral blood circu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of gastric cancer patient
  • Kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of gastric cancer patient
  • Kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of gastric cancer patient

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0046] Example 1

[0047] 1. Use a membrane filtration device to separate and obtain CTC in the peripheral blood of patients with advanced or recurrent gastric cancer who cannot obtain tissue samples to determine whether CTC exists:

[0048] Collect 5ml of fasting blood for 8-12 hours from the median cubital vein, and use 45ml of diluent (composition: 1mmol / L EDTA+0.1% BSA+ 0.1~10g / L soluble protein+0.1% polyglycerol fatty acid ester+PBS buffer 150mmol / L, where the percentage is volume ratio) Dilute the peripheral blood, then add 3ml of 4% paraformaldehyde to fix the diluted blood sample for 10 minutes;

[0049] In a fixed interval, assemble the membrane filtration device: as attached figure 1 , figure 2 , image 3 As shown, the filtering device is composed of a filter 3, a filter membrane 7, a blood sample container 2, a waste liquid tank 5, and an iron stand 1;

[0050] Wet the filter 3 with 10ml PBS, and then add the fixed peripheral blood sample to the blood sample container 2 o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of a gastric cancer patient. CTCs in peripheral blood of advanced or recurrent gastric cancer patients whose tissue specimens cannot be obtained are obtained through separation by utilizing a membrane filtration device, and CEA expression conditions of the CTCs are further detectedby utilizing an immunohistochemical technology. According to the detection method provided by the invention, the CEA expression condition of a patient suffering from advanced or recurrent gastric cancer can be detected without obtaining a tissue specimen through needle biopsy. The technology belongs to minimally invasive technology and can realize real-time detection. According to the method provided by the invention, a false positive result caused by an edge effect possibly generated in the dyeing process can be avoided, the stability is high, the cell loss is reduced, and the detection accuracy is improved.

Description

technical field [0001] The invention provides a kit and a detection method for detecting CEA gene mutation of peripheral blood circulating tumor cells of gastric cancer patients, belonging to the technical field of molecular biology. Background technique [0002] Gastric cancer (GC) is a highly fatal malignant tumor with the fourth highest incidence in the world (950,000 new cases per year), and the third highest among cancer-related deaths in 2012. Although the diagnosis and treatment methods of gastric cancer have improved in recent years, the 5-year survival rate of gastric cancer patients is less than 30%, and about 50% of gastric cancer patients suffer from tumor recurrence or metastasis after curative resection. Tumor recurrence and metastasis are the main causes of death in gastric cancer patients. [0003] Circulating tumor cells (CTCs) are tumor cells shed from solid tumors and enter the peripheral blood circulation. Since their discovery in 1989, a variety of meth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/574G01N33/569B01D29/05
CPCB01D29/05G01N33/56966G01N33/57446G01N33/57473
Inventor 李琛琛洪瑛侯景阳李文涛
Owner 山东凯歌智能机器有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap